1,681 results on '"FitzGerald, Garret A"'
Search Results
152. Bioactive lipids in antiviral immunity
153. The roles of lipids in SARS-CoV-2 viral replication and the host immune response
154. GCG100649, A Novel Cyclooxygenase-2 Inhibitor, Exhibits a Drug Disposition Profile in Healthy Volunteers Compatible With High Affinity to Carbonic Anhydrase-I/II: Preliminary Dose–Exposure Relationships to Define Clinical Development Strategies
155. COX-2 in play at the AHA and the FDA
156. Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis
157. Traditional nonsteroidal anti-inflammatory drugs and postmenopausal hormone therapy: a drug-drug interaction?
158. Molecular Clocks in Pharmacology
159. Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison
160. COX-2-derived prostacyclin protects against bleomycin-induced pulmonary fibrosis
161. Genetic model of selective COX2 inhibition reveals novel heterodimer signaling
162. Cyclooxygenases, microsomal prostaglandin E synthase-1, and cardiovascular function
163. Guidelines for the design and conduct of human clinical trials on ingestion-time differences – chronopharmacology and chronotherapy – of hypertension medications
164. Outpatient surgical management of non‐melanoma skin cancers of the head and neck in a regional centre: an analysis of costs and outcomes
165. Loci influencing blood pressure identified using a cardiovascular gene-centric array
166. Characterization of a Novel Hemoglobin-Glutathione Adduct That Is Elevated in Diabetic Patients
167. MEDICINE: Can Intellectual Property Save Drug Development?
168. Prostaglandin Mediators
169. Nitecap: An Exploratory Circadian Analysis Web Application.
170. Foreword
171. Prostaglandins and Other Lipid Mediators in Reproductive Medicine
172. Contributors
173. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin
174. The coxibs, selective inhibitors of cyclooxygenase-2
175. Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock
176. Deletion of cyclooxygenase 2 in mouse mammary epithelial cells delays breast cancer onset through augmentation of type 1 immune responses in tumors
177. Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation
178. Chapter 4 - Steroid Hormones and Other Lipid Molecules Involved in Human Reproduction
179. Sexual dimorphism in body clocks
180. Reopening schools during COVID-19
181. Accounting for Time: Circadian Rhythms in the Time of COVID-19
182. Research on COVID-19 through patient-reported data: a survey for observational studies in the COVID-19 pandemic
183. Loss of Circadian Protection in Adults Exposed to Neonatal Hyperoxia
184. Bmal1 Deletion in Myeloid Cells Attenuates Atherosclerotic Lesion Development and Restrains Abdominal Aortic Aneurysm Formation in Hyperlipidemic Mice
185. Academia Europaea Position Paper on Translational Medicine: The Cycle Model for Translating Scientific Results into Community Benefits
186. The role of Thymic Stromal Lymphopoietin (TSLP) in protection from Type II diabetes
187. Pharmacological Characterization of the Microsomal Prostaglandin E2 Synthase-1 Inhibitor AF3485 In Vitro and In Vivo
188. Misguided drug advice for COVID-19
189. Myeloid cell mPGES-1 mediates inflammatory pain hypersensitivity in mice
190. Sex dependent compensatory mechanisms to preserve blood pressure homeostasis in PGI2 receptor deficient mice
191. Noninvasive Assessment of the Role of Cyclooxygenases in Cardiovascular Health: A Detailed HPLC/MS/MS Method
192. Thromboxane Generation
193. Contributors
194. Drug development needs a new brand of science: We need to break with the past to develop new medicines, says Garret FitzGerald. An interdisciplinary NIH centre points the way.
195. Abstract B33: Tumor cell-intrinsic EPHA2 suppresses antitumor immunity by regulating PTGS2 (COX-2) in pancreatic adenocarcinoma
196. Perestroika in Pharma: Evolution or Revolution in Drug Development?
197. Platelets, Pyrexia, and Plasmodia
198. Peripheral Clocks and the Regulation of Cardiovascular and Metabolic Function
199. Cardiovascular hazard and non-steroidal anti-inflammatory drugs
200. Diels-Alder approach to isoprostanes. Total synthesis of iPF2alpha-V
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.